Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Cysteamine for Corneal Cystine Crystal Accumulation in Cystinosis
NCT00001213Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Apr 1986
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cysteamine in cystinosis, sponsored by National Eye Institute. Primary endpoints: Corneal Cystine Crystal Score Response up to 19 years and Number of Participants With Serious and Non-Serious Adverse Events up to 27 years. Started Apr 1986; status: completed.
02
Drugs
cysteamine
03
Conditions
cystinosis
Beyond the preview
Go deeper on NCT00001213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001213.